These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Etoposide and split-dose cisplatin in bronchogenic carcinoma.
    Author: Lauer RC, Fisher WB, Pennington K, Ansari R, Einhorn LH, Loehrer PJ.
    Journal: Am J Clin Oncol; 1988 Dec; 11(6):634-5. PubMed ID: 3189229.
    Abstract:
    The Hoosier Oncology Group (HOG) treated 13 patients with bronchogenic carcinoma with an innovative schedule of cisplatin and VP-16. Unexpected toxicity was noted, with five deaths secondary to granulocytopenia and septic shock and three episodes of renal failure. Despite early closure of this study, we conclude that this schedule of cisplatin and VP-16 results in greater toxicity than comparable dosages in a more routine schedule.
    [Abstract] [Full Text] [Related] [New Search]